IBRX
IMMUNITYBIO (IBRX)
NASDAQ
$7.37+$0.15 (+2.08%)
Price as of Jun 23, 2026 7:09 PM EDT
  • $7.6B
    Market Cap
  • 161.59%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 37
Valuation
IBRX
vs History
vs S&P 500
Profitability
-0
Growth
-0
Low Earnings Volatility
0

Momentum Score

Score: 81
Valuation
IBRX
vs History
vs S&P 500
3-Month Momentum
-5.96%
12-Month Momentum
180.49%
3-Month Risk Adjusted Momentum
-13.88%
12-Month Risk Adjusted Momentum
175.90%

True Yield

N/A
Valuation
IBRX
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
0.16%
Net Debt Paydown Yield
-8.21%

Financial Health Score

Score: 64
Valuation
IBRX
vs History
vs S&P 500
Ohlson's O-Score
-1